Christoph Broja is a Partner at EQT Life Sciences based in Munich, focusing on venture and growth investments in biotech, pharma, and medical devices. He has extensive experience across the entire investment process and holds a degree in Business Administration and a CFA Charter. People often describe him as collaborative and inquisitive.
During a recent podcast interview, Christoph emphasized the importance of being intellectually curious and a lifelong learner, especially in a fast-paced innovative environment like biotechnology. He notes that this curiosity is what keeps his work engaging and never boring.
He played a key role as a board member for Cardior Pharmaceuticals, which was acquired by Novo Nordisk for up to €1 billion.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.